CORAL GABLES, FL/ ACCESSWIRE / January 22, 2019 / The marijuana stock market has seen some of the best days in its history over the course of the past two weeks or so. Since the passing of the US Farm Bill, companies in the cannabis industry have been working to build out their hemp operations and manufacturing. While legal hemp may not seem like a huge indicator for marijuana to rise, to the correlation between the two is staggering. Market analysts have stated that this could be the year of cannabis as the market continues to make solid strides in the right direction. With the new year already one month older, Premier Health Group (PHGRF) (PHGI) , Cronos Group Inc (NASDAQ:CRON), Aphria Inc (NYSE:APHA) (TSX:APHA.TO), and Canopy Growth Corporation (NYSE:CGC) are four pot stocks worth looking into on Tuesday.
Premier Health Group (PHGRF) (PHGI) has seen impressive gains in the past couple weeks of trading, as the cannabis sector has garnered more favorable opinions among investors and consumers following the recent passing of certain pieces of legislation.
Recently, Premier has focused its efforts on investing in opportunities which look to strengthen the duality of healthcare and cannabis to develop a business model that targets several key issues areas for their patients.
Earlier last week, Premier Health Group (PHGRF) (PHGI) announced that as part of its international expansion strategy, it has entered into a strategic partnership with China’a 360 Health, a healthcare subsidiary of 360 Security Technology. The parent company, 360 Security Technology, is a leading online service company in China with a market capitalization of over $20 billion USD as of January 16, 2019. As part of the collaboration, Premier and 360 Health will implement an infrastructure whereby Premier will be providing second opinion services by connecting 360 Health’s patients in China with doctors in Canada both remotely and in person. Premier will also assist with General Practitioner training virtually and onsite through medical seminars.
In response to this announcement , Dr. Essam Hamza, CEO of Premier, said, “We are very excited to be working with 360 Health as China continues to adopt a Family Practice primary care model and look forward to helping them establish themselves as a leader in primary care. This partnership represents an excellent opportunity for Premier to tap into the fastest growing telemedicine market globally.”
Cronos Group Inc (CRON) announced at the end of last week that all meeting materials for a special meeting of holders of common shares of the Company to be held on February 21, 2019, including the management proxy circular dated December 31, 2018, prepared in connection with the proposed C$2.4 billion investment by Altria Group, Inc, have been mailed to Shareholders and filed with relevant Canadian securities regulators.
Aphria Inc (APHA) announced towards the end of last week that the Company had entered into an exclusive agreement with Toronto-based UNOapp Inc to collaborate on the development of technology and analytics solutions for Canada’s growing adult-use cannabis market.
Following the announcement, Jakob Ripshtein, President of Aphria, said, “With our innovation-focused approach, Aphria is setting the pace for the evolution of the adult-use cannabis industry in Canada. Our industry’s long-term future will be driven by consumer-centric, innovation-led product, brand and technology solutions. We are excited about this collaboration with a fantastic technology partner in UNOapp and look forward to developing industry-leading solutions that shape the adult-use cannabis market for years to come.”
Canopy Growth Corporation (CGC) yesterday announced major updates their progress in European markets, specifically in the UK and Poland where its medically-focused business Spectrum Cannabis continues to build a cannabis production and distribution network.
In a press release regarding the update, Dr. Mark Ware, Chief Medical Officer of Canopy Growth, said, “There is significant real-world and clinical evidence supporting the safety and effectiveness of cannabis-based medicinal products. However, due to the current regulations and lack of education about medicinal cannabis among clinicians in the UK, there remain considerable obstacles to patient access. Spectrum UK has the expertise and ambition to simplify the UK medicinal cannabis landscape and ensure access to cannabis-based medicinal products for patients with great clinical unmet need.”
What Is Stock Price (StockPrice.com)?
Stock Price is defined as the price of a single share of a number of saleable stocks of a public company. A stock price is the highest amount an investor or trader is willing to pay for the stock, or the lowest amount that it can be bought for.
StockPrice.com was created for everyone that wants the latest stock quotes, stock charts, company news, and the best financial content.
At Stock Price (StockPrice.com), you get free stock quotes, up-to-date news, international market data, social interaction and the best financial content that will help you manage your financial life.
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. JSG Communications, LLC which owns www.StockPrice.com is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release.
JSG Communications, LLC, which owns www.StockPrice.com , may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. JSG Communications, LLC, which owns www.StockPrice.com , may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two.
Pursuant to an agreement between MIDAM VENTURES, LLC an affiliate of JSG COMMUNICATIONS LLC and Premier Health Group Inc. we were hired for a period from 10/1/2018 – 4/1/2019 to publicly disseminate information about Premier Health Group Inc. including on the Website and other media including Facebook and Twitter. We were paid $300,000 (CASH) for & were paid “500,000” shares of restricted common shares (as of 1/22/2019). We own zero shares of Premier Health Group Inc., which we purchased in the open market. Once the (6) Six-month restriction is complete on 4/1/2019 we plan to sell the “500,000” shares of Premier Health Group Inc. that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information Please click here for full disclaimer .